Maria E. Rodriguez-Aguirre

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

Timothy F. Cloughesy, Joseph Landolfi, Daniel J. Hogan et al. · Science Translational Medicine · 2016 · 196 citations

Oncologic Imaging, Pathology, Recurrent High-grade Glioma +19

Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase

Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons et al. · Nature · 2024 · 88 citations

Molecular Recognition, Biochemistry, Natural Sciences +6

Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model

Tiffany Huang, Juraj Hlavatý, Derek Ostertag et al. · Cancer Gene Therapy · 2013 · 53 citations

Neuro-oncology, Medicine, Temozolomide-sensitive Glioblastoma Model +10

A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models

Kader Yagiz, Maria E. Rodriguez-Aguirre, Fernando Lopez Espinoza et al. · Molecular Therapy — Oncolytics · 2017 · 34 citations · Full text

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models

Leah Mitchell, Kader Yagiz, Andrew Hofacre et al. · Oncotarget · 2019 · 12 citations · Full text